HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alterations in Ca2+ cycling proteins and G alpha q signaling after left ventricular assist device support in failing human hearts.

AbstractOBJECTIVE:
Left ventricular assist device support mechanically unloads the failing ventricle with resultant improvement in cardiac geometry and function in patients with end-stage heart failure. Activation of the G alpha q signaling pathway, including protein kinase C, appears to be involved in the progression of heart failure. Similarly down-regulation of Ca2+ cycling proteins may contribute to contractile depression in this clinical syndrome. Thus we examined whether protein kinase C activation and decreased Ca2+ cycling protein levels could be reversed by left ventricular assist device support.
METHODS:
Left ventricular myocardial specimens were obtained from seven patients during placement of left ventricular assist device and heart transplantation. We examined changes in protein levels of G alpha q, phospholipase C beta 1, regulators of G protein signaling (RGS), sarcoplasmic reticulum Ca2+ ATPase, phospholamban and translocation of protein kinase C isoforms (alpha, beta 1, and beta 2).
RESULTS:
The paired pre- and post-left ventricular assist device samples revealed that RGS2, a selective inhibitor of G alpha q, was decreased (P < 0.01), while the status of G alpha q, phospholipase C beta 1, RGS3 and RGS4 were unchanged after left ventricular assist device implantation. Translocation of protein kinase C isoforms remained unchanged. Left ventricular assist device support increased sarcoplasmic reticulum Ca2+ ATPase protein level (P < 0.01), while phospholamban abundance was unchanged.
CONCLUSIONS:
We conclude that altered protein expression and stoichiometry of the major cardiomyocyte Ca2+ cycling proteins rather than reduced phospholipase C beta 1 activation may contribute to improved mechanical function produced by left ventricular assist device support in human heart failure.
AuthorsY Takeishi, T Jalili, B D Hoit, D L Kirkpatrick, L E Wagoner, W T Abraham, R A Walsh
JournalCardiovascular research (Cardiovasc Res) Vol. 45 Issue 4 Pg. 883-8 (Mar 2000) ISSN: 0008-6363 [Print] England
PMID10728414 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Calcium-Binding Proteins
  • Isoenzymes
  • RGS Proteins
  • Rgs2 protein, mouse
  • phospholamban
  • Protein Kinase C
  • GTP-Binding Proteins
  • Calcium-Transporting ATPases
Topics
  • Adolescent
  • Adult
  • Calcium-Binding Proteins (metabolism)
  • Calcium-Transporting ATPases (metabolism)
  • Case-Control Studies
  • Female
  • GTP-Binding Proteins (metabolism)
  • Heart Failure (metabolism, therapy)
  • Heart-Assist Devices
  • Humans
  • Immunoblotting
  • Isoenzymes (metabolism)
  • Male
  • Middle Aged
  • Myocardium (metabolism)
  • Protein Kinase C (metabolism)
  • RGS Proteins (metabolism)
  • Sarcoplasmic Reticulum (drug effects, enzymology)
  • Signal Transduction (physiology)
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: